Regular exercise training prevents aortic valve disease in low-density lipoprotein-receptor-deficient mice

Circulation

Volumn 121, Issue 6, 2010, Pages 759-767

  Matsumoto, Yasuharu ^a   Adams, Volker ^a   Jacob, Saskia ^a   Mangner, Norman ^a   Schuler, Gerhard ^a   Linke, Axel ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Calcification; Exercise; Inflammation; Prevention; Valves

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; BONE MORPHOGENETIC PROTEIN 2; FETUIN A; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE; TRANSCRIPTION FACTOR RUNX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE; AORTA VALVE DISEASE; AORTIC VALVE SCLEROSIS; ARTICLE; BLOOD FLOW VELOCITY; CALCIFICATION; CELL ACTIVATION; CHOLESTEROL DIET; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FIBROSIS; GENE EXPRESSION; HISTOPATHOLOGY; INFLAMMATION; KINESIOTHERAPY; LIPID METABOLISM; MACROPHAGE MIGRATION INHIBITION; MINERALIZATION; MOUSE; MYOFIBROBLAST; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THICKNESS; TRICUSPID VALVE;

ANIMALS; AORTIC VALVE; CELL COUNT; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HEART VALVE DISEASES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OXIDATIVE STRESS; PEROXIDASE; PHYSICAL CONDITIONING, ANIMAL; RECEPTORS, LDL; RISK FACTORS; SUPEROXIDES;

EID: 77149165705     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.892224     Document Type: Article

References (43)

1. Otto CM. Calcific aortic stenosis: time to look more closely at the valve. N Engl J Med. 2008;359:1395-1398.
2. Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol. 2007;50:1205-1213.
3. Helske S, Otto CM. Lipid lowering in aortic stenosis: still some light at the end of the tunnel? Circulation. 2009;119:2653-2655.
4. Miller JD, Weiss RM, Serrano KM, Brooks RM II, Berry CJ, Zimmerman K, Young SG, Heistad DD. Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. Circulation. 2009;119: 2693-2701.
5. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G, Baumgartner H. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000;343:611-617.
6. O'Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol. 2006;26:1721-1728.
7. Agmon Y, Khandheria BK, Meissner I, Sicks JR, O'Fallon WM, Wiebers DO, Whisnant JP, Seward JB, Tajik AJ. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol. 2001;38:827-834.
8. Aikawa E, Aikawa M, Libby P, Figueiredo JL, Rusanescu G, Iwamoto Y, Fukuda D, Kohler RH, Shi GP, Jaffer FA, Weissleder R. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation. 2009;119:1785-1794.
9. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, Barnes ME, Tajik AJ. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290-3295.
10. Laufs U, Wassmann S, Czech T, Munzel T, Eisenhauer M, Bohm M, Nickenig G. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis. Arterioscler Thromb Vasc Biol. 2005; 25:809-814.
11. Hambrecht R, Niebauer J, Marburger C, Grunze M, Kalberer B, Hauer K, Schlierf G, Kubler W, Schuler G. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol. 1993;22:468-477.
12. Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, Baither Y, Gielen S, Thiele H, Gummert JF, Mohr FW, Schuler G. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation. 2003;107:3152-3158.
13. Adams V, Linke A, Krankel N, Erbs S, Gielen S, Mobius-Winkler S, Gummert JF, Mohr FW, Schuler G, Hambrecht R. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation. 2005;111: 555-562.
14. Pynn M, Schafer K, Konstantinides S, Halle M. Exercise training reduces neointimal growth and stabilizes vascular lesions developing after injury in apolipoprotein E-deficient mice. Circulation. 2004;109:386-392.
15. Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M, Weissleder R. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007; 115:377-386.
16. Drolet MC, Roussel E, Deshaies Y, Couet J, Arsenault M. A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. J Am Coll Cardiol. 2006;47:850-855.
17. Lee JC, Zhao X, Otto CM. Aortic valve sclerosis. J Echocardiogr. 2005;3:51-59.
18. Antonini-Canterin F, Hirsu M, Popescu BA, Leiballi E, Piazza R, Pavan D, Ginghina C, Nicolosi GL. Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis. Am J Cardiol. 2008;102:738-742.
19. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107:3109-3116.
20. Simmons CA. Aortic valve mechanics: an emerging role for the endo-thelium. J Am Coll Cardiol. 2009;53:1456-1458.
21. Rajamannan NM, Subramaniam M, Stock SR, Stone NJ, Springett M, Ignatiev KI, McConnell JP, Singh RJ, Bonow RO, Spelsberg TC. Ator-vastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart. 2005;91:806-810.
22. Arishiro K, Hoshiga M, Negoro N, Jin D, Takai S, Miyazaki M, Ishihara T, Hanafusa T. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholester-olemic rabbits. J Am Coll Cardiol. 2007;49:1482-1489.
23. El-Hamamsy I, Balachandran K, Yacoub MH, Stevens LM, Sarath-chandra P, Taylor PM, Yoganathan AP, Chester AH. Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol. 2009;53:1448-1455.
24. Yip CY, Chen JH, Zhao R, Simmons CA. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arte-rioscler Thromb Vasc Biol. 2009;29:936-942.
25. Schoen FJ. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation. 2008;118:1864-1880.
26. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001; 103:1522-1528.
27. Weiss RM, Ohashi M, Miller JD, Young SG, Heistad DD. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation. 2006;114: 2065-2069.
28. Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak J Jr, Pomer-antzeff PM, Laurindo FR. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 2008;28:463-470.
29. Miller JD, Chu Y, Brooks RM, Richenbacher WE, Pena-Silva R, Heistad DD. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol. 2008;52:843-850.
30. Demer LL. Cholesterol in vascular and valvular calcification. Circulation. 2001;104:1881-1883.
31. Mohty D, Pibarot P, Despres JP, Cote C, Arsenault B, Cartier A, Cosnay P, Couture C, Mathieu P. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol. 2008;28:187-193.
32. Malle E, Furtmuller PG, Sattler W, Obinger C. Myeloperoxidase: a target for new drug development? Br J Pharmacol. 2007;152:838-854.
33. Richter B, Niessner A, Penka M, Grdic M, Steiner S, Strasser B, Ziegler S, Zorn G, Maurer G, Simeon-Rudolf V, Wojta J, Huber K. Endurance training reduces circulating asymmetric dimethylarginine and myeloper-oxidase levels in persons at risk of coronary events. Thromb Haemost. 2005;94:1306-1311.
34. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, Mobius-Winkler S, Schubert A, Schuler G, Hambrecht R. Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle. Circulation. 2005;111: 1763-1770. (Pubitemid 40525140)
35. Heistad DD, Wakisaka Y, Miller J, Chu Y, Pena-Silva R. Novel aspects of oxidative stress in cardiovascular diseases. Circ J. 2009;73:201-207.
36. Park JH, Iemitsu M, Maeda S, Kitajima A, Nosaka T, Omi N. Voluntary running exercise attenuates the progression of endothelial dysfunction and arterial calcification in ovariectomized rats. Acta Physiol (Oxf). 2008;193:47-55.
37. Wilund KR, Tomayko EJ, Evans EM, Kim K, Ishaque MR, Fernhall B. Physical activity, coronary artery calcium, and bone mineral density in elderly men and women: a preliminary investigation. Metabolism. 2008; 57:584-591.
38. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobio-logical mechanisms and clinical implications. Circ Res. 2006;99: 1044-1059.
39. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 2003;107:2181-2184.
40. Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation. 2007;115:2533-2539.
41. Koos R, Brandenburg V, Mahnken AH, Muhlenbruch G, Stanzel S, Gunther RW, Floege J, Jahnen-Dechent W, Kelm M, Kuhl HP. Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients. Eur Heart J. 2009;30:2054-2061.
42. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: patho-genesis, disease progression, and treatment strategies. Circulation. 2005; 111:3316-3326.
43. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270-274.